Featured Research

from universities, journals, and other organizations

No increase in severe cardiovascular events for children, adolescents taking ADHD medications, study finds

Date:
May 16, 2011
Source:
University of Pennsylvania School of Medicine
Summary:
Despite recent concerns that medications for attention deficit hyperactivity disorder (ADHD) could increase the risk of cardiovascular events in children and adolescents, an observational study conducted by researchers finds they are no more likely to die from a severe cardiovascular event than those who do not take the drugs. The findings provide the first analysis of such events in a large population of children and adolescents receiving ADHD medications compared to non-users.

Despite recent concerns that medications for attention deficit hyperactivity disorder (ADHD) could increase the risk of cardiovascular events in children and adolescents, an observational study conducted by researchers at the University of Pennsylvania School of Medicine and HealthCore Inc. finds they are no more likely to die from a severe cardiovascular event than those who do not take the drugs. The findings, published online in the journal Pediatrics, provide the first analysis of such events in a large population of children and adolescents receiving ADHD medications compared to non-users.

"These data provide reassurance that the thing most concerning -- death -- is not any higher in users of ADHD medications than non-users," says senior author Sean Hennessy, PharmD, PhD, an associate professor of Epidemiology at Penn. "For kids who will benefit from ADHD treatment, the potential risk of a cardiovascular event should not dissuade parents or caregivers from giving a child or adolescent these drugs."

An estimated 2.7 million or 4.8 percent of all children in the U.S. ages 4-17 took ADHD medications in 2007, the most recent year for which data are available. After previous studies found drugs to treat ADHD can lead to increased heart rate and blood pressure in children, Hennessy's group turned to a large database of patient records to see if patients who recently began taking ADHD medications appeared any more likely to suffer from sudden death, heart attack, or stroke.

For the study, researchers sifted through patient data contained in Medicaid databases from five states (CA, FL, PA, NY, OH) and the HealthCore Integrated Research Database, which contains historical and current medical and pharmacy claims data from more than 44 million enrollees in Blue Cross and Blue Shield plans in 14 states. Hennessy's group identified 241,417 patients ages 3-17 on ADHD medications and tracked their health records during the period they were on medication (a median of 135 days). The researchers then compared rates of sudden death, heart attack, and stroke in patients taking ADHD medications to those not taking medications who were of the same age, sex and from the same state over a median of 609 days.

The researchers found 28 deaths in the group exposed to ADHD medications (incidence 1.79 per 10,000 person-years) and 607 in the control group (incidence 3.00 per 10,000 person-years). Additionally, the researchers identified no cases of heart attack or stroke in the group who received ADHD medications and 11 cases in the unexposed group. Because the group of children and adolescents receiving ADHD medications had no validated reports of stroke and heart attack, researchers were unable to rule out relative increases in the rate of such events from use of the drugs.

"The fact that the rates of cardiovascular events that could be identified were very low is of interest because at least we can tell that we do not have an epidemic of such events in kids receiving ADHD drugs," Hennessy says. "If ADHD medications were causing an epidemic of cardiovascular events, we would expect to see it in this study."

"This is one of first answers but it won't be the last," Hennessy says, adding that since 2007, the U.S. Food and Drug Administration (FDA) and Agency for Healthcare Research and Quality (AHRQ) has been looking into the potential cardiovascular risks of ADHD medications on children. "Until the results of the FDA study become public, this study should provide reassurance to parent and caregivers that ADHD drugs are safe from cardiovascular perspective."

Other authors of the study included Hedi Schelleman, PhD, Warren B. Bilker, PhD, Brian L. Strom, MD, MPH, Stephen E. Kimmel, MD, MSCE, Craig Newcomb, MS, James P. Guevara, MD, MPH, all from Penn, and Gregory W. Daniel, RPh, PhD, MPH, and Mark J. Cziraky, PharmD, CLS, FAHA, all from HealthCore Inc.


Story Source:

The above story is based on materials provided by University of Pennsylvania School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hedi Schelleman, Warren B. Bilker, Brian L. Strom, Stephen E. Kimmel, Craig Newcomb, James P. Guevara, Gregory W. Daniel, Mark J. Cziraky, Sean Hennessy. Cardiovascular Events and Death in Children Exposed and Unexposed to ADHD Agents. Pediatrics, 2011; DOI: 10.1542/peds.2010-3371

Cite This Page:

University of Pennsylvania School of Medicine. "No increase in severe cardiovascular events for children, adolescents taking ADHD medications, study finds." ScienceDaily. ScienceDaily, 16 May 2011. <www.sciencedaily.com/releases/2011/05/110516075923.htm>.
University of Pennsylvania School of Medicine. (2011, May 16). No increase in severe cardiovascular events for children, adolescents taking ADHD medications, study finds. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2011/05/110516075923.htm
University of Pennsylvania School of Medicine. "No increase in severe cardiovascular events for children, adolescents taking ADHD medications, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/05/110516075923.htm (accessed September 21, 2014).

Share This



More Health & Medicine News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins